Cargando…
Detoxified O-Specific Polysaccharide (O-SP)–Protein Conjugates: Emerging Approach in the Shigella Vaccine Development Scene
Shigella is the second most common cause of moderate to severe diarrhea among children worldwide and of diarrheal disease-associated mortality in young children in low-and middle-income countries. In spite of many years of attempts to develop Shigella vaccines, no licensed vaccines are yet available...
Autores principales: | Cohen, Dani, Meron-Sudai, Shiri, Bialik, Anya, Asato, Valeria, Ashkenazi, Shai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145086/ https://www.ncbi.nlm.nih.gov/pubmed/35632431 http://dx.doi.org/10.3390/vaccines10050675 |
Ejemplares similares
-
Threshold protective levels of serum IgG to Shigella lipopolysaccharide: re-analysis of Shigella vaccine trials data
por: Cohen, Dani, et al.
Publicado: (2023) -
Pentraxin 3 and Shigella LPS and IpaB Antibodies Interplay to Defeat Shigellosis
por: Meron-Sudai, Shiri, et al.
Publicado: (2022) -
A Shigella flexneri 2a synthetic glycan-based vaccine induces a long-lasting immune response in adults
por: Meron-Sudai, Shiri, et al.
Publicado: (2023) -
Shigella-specific antibodies in the first year of life among Zambian infants: A longitudinal cohort study
por: Chisenga, Caroline C., et al.
Publicado: (2021) -
Further characterization of Shigella-specific (memory) B cells induced in healthy volunteer recipients of SF2a-TT15, a Shigella flexneri 2a synthetic glycan-based vaccine candidate
por: Toapanta, Franklin R., et al.
Publicado: (2023)